Earnings

Envoy Medical Q3 EPS $(0.50) Beats $(0.67) Estimate, Sales $66.000K Miss $86.667K Estimate

Nov 5, 2026 · 07:46 AM ET· updated 2h ago

Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.67) by 25.37 percent. This is a 42.86 percent decrease over losses of $(0.35) per share from

Why It Matters

Envoy Medical lost less money per share than expected, which is good. However, their sales came in way below what people predicted, which is concerning.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

COCH7.11

+0.49 (+7.40%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.